← Back to Clinical Trials
Recruiting NCT07296861

NCT07296861 HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Development of Young Children With Down Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07296861
Status Recruiting
Phase
Sponsor UNC Lineberger Comprehensive Cancer Center
Condition Down Syndrome
Study Type INTERVENTIONAL
Enrollment 38 participants
Start Date 2026-03-01
Primary Completion 2027-05

Trial Parameters

Condition Down Syndrome
Sponsor UNC Lineberger Comprehensive Cancer Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 38
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2026-03-01
Completion 2027-05
Interventions
The HomeGrownWaitlist

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this project is to evaluate an adapted health promotion program, HomeGrown, designed to improve the health of young children with Down syndrome by supporting families in making healthy home environmental changes. There is a significant need for evidence-based programs that address healthy eating and physical activity within this population, as most existing interventions have been developed for typically developing children. By tailoring the program to the unique needs of families of young children with Down syndrome, this project aims to advance inclusion and equity in health behavior promotion. This R61/R33 study will assess the feasibility (R61 Phase) and subsequent efficacy (R33 Phase) of the HomeGrown program in improving family practices related to nutrition and physical activity. During the R61 feasibility phase, 38 primary caregivers of children aged 2-6 years with Down syndrome will be enrolled in a 6-month randomized controlled trial. Families will be randomized 1:1 to either the HomeGrown intervention or a waitlist control group (6-month delayed start), stratified by the child's biological sex (male/female) and age (2-3 vs. 4-6 years). All measures will be collected at baseline and at 6-month follow-up. The R61 feasibility phase will address three specific aims: Accrual: Achieve an enrollment rate of 10 families per month, supporting feasibility for the R33 efficacy phase. Engagement: Demonstrate that families use at least 70% of available HomeGrown intervention components, measured using the digital behavior change interventions engagement scale. Data Collection \& Retention: Achieve at least 80% retention with completion of all outcome assessments. By addressing key gaps in nutrition and physical activity research for young children with Down syndrome, this study has the potential to improve health outcomes for an underserved population and inform future clinical and community health promotion efforts.

Eligibility Criteria

Inclusion Criteria: Adult: * Ability to provide informed consent * 18 years or older * Primary caregiver of a child with Down syndrome aged 2 to 6 years old * Have access to WI-FI or smartphone * Be able to read and speak English Children: * Be 2-6 years old. * Are diagnosed with Down syndrome * Are not reliant on tube feeding Exclusion Criteria: \-

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology